Shandong Cancer Hospital And Institute

This study is testing whether adding a precise, high-dose form of radiation (SBRT) to standard drug therapy helps people with advanced liver cancer live longer than drug therapy alone. It will involve about 184 participants who have cancer that has spread within the liver or to o…

This study is for people with advanced head and neck cancer who cannot receive standard platinum-based chemotherapy. It compares standard radiation therapy alone to radiation combined with a targeted drug called nimotuzumab. The goal is to see if adding nimotuzumab helps control …

This study is testing if adding an existing antifungal drug, posaconazole, to standard chemotherapy and immunotherapy can improve treatment results for patients with triple-negative breast cancer before surgery. Researchers aim to see if this combination helps more patients achie…

This study is for people with colorectal cancer who had no signs of disease but then developed a few small spots (metastases) in their lungs. It tests whether patients can safely delay starting a new round of chemotherapy after these lung spots are treated with local methods like…

This study is testing whether a special nano-formulated version of an existing appetite drug (megestrol acetate) can help people with advanced pancreatic cancer gain weight and feel better. It will involve 56 patients who are about to start standard chemotherapy. Half will receiv…

This study is analyzing existing research to find the best dose of the drug olanzapine for preventing severe nausea and vomiting caused by strong chemotherapy. It compares three doses (2.5mg, 5mg, and 10mg) to see if lower doses work as well as the standard 10mg dose but cause le…

This study looks back at the medical records of 300 people with early-stage, HER2-positive breast cancer who received a standard two-drug targeted therapy. Researchers want to understand if having extremely high levels of the HER2 protein is linked to a higher chance of the cance…